Abstract
Coronavirus disease 2019 (COVID-19) patients have a high incidence of gastrointestinal (GI) complications including ischemia.1 Moreover, the pooled presence of ribonucleic acid (RNA) from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in symptomatic patients was found to be 54% in fecal samples.2 Little evidence, however, is available on the potential intra-abdominal presence of the virus. Protective measures to minimize staff exposure are recommended by surgical societies worldwide, such as the Society of American Gastrointestinal and Endoscopic Surgeons and the European Association for Endoscopic Surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
